Radio Advisory

Healthcare leaders have dozens of priorities on their plates, and achieving innovation is not as simple as just buying a new technology or implementing a new care model. Frankly, it can be overwhelming not just to see innovations through, but even to get started. So, what does it really take to innovate? And how do you align your organization’s challenges with the solutions or innovations that are being presented to you? In this special episode, live from Advisory Board’s 2024 Clinical Innovation Summit, guest host and Advisory Board digital health expert John League invites Dr. Ayo Ajaiyeoba from Blue Cross Blue Shield of Kansas City, and Elliot Green, cofounder and CEO of Dandelion Health, to dive deep on the realities of innovation. Throughout the discussion, they explore what it takes to get started, how to act in the face of ambiguity, and how you should be thinking about tools like data and partnerships to achieve your goals. Links: Blue Cross Blue Shield Dandelion Health Top 5 takeaways from our Clinical Innovation Summit 4 imperatives for the future of healthcare innovation Truly personalized care is possible. Here's how to make it a reality. More upcoming events from Advisory Board Learn more about Advisory Board On-Demand Courses A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

It seems like a no-brainer for healthcare organizations to allocate time and attention to a health condition that is guaranteed to affect 50% of adults during their midlife years—but that hasn’t been the case. We’re seeing momentum around making menopause mainstream—from the White House directing research funding, to Hollywood stars talking openly about menopause, to the rise of femtech companies geared toward helping consumers navigate the clinical and social effects of menopause. But though 100% of women in midlife will experience this clinical event, the reality is that most women’s health programs are primarily focused on what our guests have referred to in the past as the “bikini approach” to women’s health, and have largely ignored the needs of women in the post-reproductive years. From a clinical and financial standpoint, this is a missed opportunity. And given 80% of the healthcare workforce is women, and one-third of those women are in midlife, it’s also a competitive vulnerability. That’s why this week, host Rachel (Rae) Woods invites Advisory Board women’s health experts Kara Marlatt and Gaby Marmolejos to explore how provider and employer leaders can build systems that account for and address women’s health needs “beyond the bikini.” Links: 5 ways employers can support women's health during midlife Five women leaders on the shifting landscape of women's health, per UnitedHealthcare (beckerspayer.com) Ep. 188: The business case for investing in women's health The business case for investing in women’s specialty care Women’s health opportunity: Menopause symptom care [Webinar, Aug. 13] Your guide to the lab and diagnostics market landscape in 2024 A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

In recent years, we’ve seen large retailers like CVS, Walgreens, Walmart, and even Amazon add to their care delivery portfolios, specifically through offering low-acuity primary care services. But it seems like the tide may be shifting. In April, Walmart announced that it’s shuttering its primary care operations and virtual care arm—and it’s not the only one scaling back. The fact is, a number of retailers are retrenching on primary care operations. In this episode, host Abby Burns invites Advisory Board experts Vidal Seegobin, Natalie Trebes, and Eliza Dailey to unpack exactly why Walmart and other retailers are pulling back on primary care delivery, and why the conventional explanation –"healthcare is too complex”– falls short. Links: Walmart Health is closing down. Here's what you need to know. Another one bites the dust: What Walmart's retreat from healthcare means for providers 5 trends (re)shaping site-of-care shifts 6 insights on consumer preferences in healthcare How Amazon, CVS, Walmart, and more are impacting provider pay Our Disruption playlist Ep. 130: Healthcare disruptors: Don't discount retailers [July 25] Understand your customer: Medical groups 101 A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

Radio Advisory first started production in April 2020 to deliver timely, critical messages to healthcare professionals navigating the early days of the Covid-19 pandemic. Four years, 200+ episodes, and one million downloads later, Radio Advisory continues to bring insightful conversations and valuable insights to listeners passionate about driving positive change in healthcare. To celebrate our millionth download, host Rachel (Rae) Woods and the Radio Advisory production team revisit some of their favorite episodes over the last four years, recollect the lessons learned, and reflect on how the healthcare industry has evolved alongside us. We owe this milestone to you, our listeners. Your support and engagement have fueled and enriched our episodes, and we look forward to bringing you many more insightful conversations. Thank you! Links: Ep. 2: How COVID-19 is transforming telehealth now and in the future Ep. 35: Zeke Emanuel on the path to a vaccine (and why it's much harder than you think) Ep. 69: CEO Warner Thomas on 20 years of digital innovation at Ochsner Health Ep. 159: Ozempic, Wegovy, and our questions on weight management drugs 3 paths to the future of obesity care (and how to get there) 5 catalysts that will impact the future of weight management drugs What the headlines get wrong about weight-management medications How Cone Health added ATTR-CM screening to an existing care pathway: A TAVR example A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

Generative AI is one of the most widely discussed topics in the industry today. There is continued excitement, mounting anxiety, and dozens of questions for health leaders to answer. While the healthcare industry has been working tirelessly to adapt to the almost unbelievable rate of change, many organizations struggle with how to ethically implement and scale Artificial Intelligence. This week, host Rachel (Rae) Woods invites Duke University Health System's Chief Information Officer, Dr. Eric Poon, to discuss how Duke has approached ethical implementation of AI—and how their efforts started long before ChatGPT existed. Throughout the conversation, they discuss the early challenges Duke faced, offer tactical guidance for successful implementation, and explain why proper governance is critical to ethical AI adoption. Links: Duke Health | Connect with your health care at Duke Health The best AI strategy isn't about AI AI in healthcare: Insights from 10 C-suite executives Ep. 180: Tom Lawry on why AI has a PR problem Using simplified clinical criteria to screen more patients for ATTR-CM Learn about Advisory Board Fellowship A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

The healthcare industry has been rocked by the pandemic and thrown headfirst into a new era of technological and therapeutic revolution. Yet, in the midst of all this change and uncertainty, healthcare leaders are expected not just to survive, but actually drive value for their organizations, patients, and communities. The problem is, “driving value” is not only complex, but it’s also ambiguous. Leaders who talk about value across the industry may not even be talking about the same thing. So, how should the industry think about driving value and what does it take to get this right? In this episode, live from Advisory Board’s 2024 Value Summit, host Abby Burns invites Stacey Richter, healthcare entrepreneur, co-president of Aventria Health Group, and host of the Relentless Health Value podcast, to break down what “value” in healthcare actually means, where organizations go wrong, and how we can work to improve value across the industry. Links: Raising the Value Bar Virtual Summit Our Value-Based Care playlist EP358: How Health Insurance Plan Design Can Lead to Patients Sacrificing Needed Care, Their Mental Health, and (Sometimes) Buying Groceries, With Wayne Jenkins, MD | Relentless Health Value™ EP391: Lessons for Private Equity and Others Trying to Do Right by PCPs and Their Patients, With Scott Conard, MD | Relentless Health Value™ EP427: How Do Digital Health Vendors Deliver Patient Outcomes and Experiences? With Rik Renard | Relentless Health Value™ EP432: The Knifepoint Intersection of Margin and Mission and the Peril of Cutting Clinical “Waste,” With Kate Wolin, ScD | Relentless Health Value™ The challenges with migraine care — and what health systems can do about it A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

The rise of generative AI has impacted healthcare in many ways – one of which is that it’s pushing Big Tech toward becoming not just a relevant, but a central player in the industry. And when we’re talking Big Tech, we have to include Google. Google’s activity in healthcare has been turbulent since it entered the space nearly two decades ago, but it’s impossible to deny the significance of the contributions it’s made to the industry. Now with the rapid growth of genAI, Google is refining its healthcare strategy to drive maximum impact in the areas it’s best positioned to – places like consumer, therapeutics, diagnostics, and more. At the forefront of this work is Dr. Karen DeSalvo, Google’s Chief Health Officer. This week, guest host Eric Larsen, President Emeritus of Advisory Board and President of Towerbrook Advisors sits down with Dr. DeSalvo to unpack the seemingly boundless opportunities of generative AI to evolve healthcare and the unique—and scoped—role Google is playing in helping advance that evolution. Links: Lessons from the C-suite AI in healthcare: Insights from 10 C-suite executives Ep. 197: Lessons from the C-Suite: Demystifying generative AI with Dr. John Halamka, President of Mayo Clinic Platform Ep. 185: AI adoption: why you can't afford to "wait and see" Ep. 180: Tom Lawry on why AI has a PR problem The chronic condition we should be talking about: Challenges and opportunities in migraine care Learn about Advisory Board Fellowship A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

So far in our series on bespoke care and innovation, we’ve delved into the future of cancer care and the opportunities for equity in precision medicine. But we can’t conclude our series without talking about one of the most exciting developments in the field: cell and gene therapies. We’ve talked about these therapies on the pod before—but like everyone else, we’ve primarily focused on the payment side of the equation and looked at how purchasers and pharma can work together to ensure patient access. These conversations miss the voice of a key stakeholder: providers. What is the role of the provider organizations in realizing the value of cell and gene therapies? To answer that question, in the final episode of our series leading up to Advisory Board’s Clinical Innovation Summit: Revolutions in Specialty Care, host Rachel (Rae) Woods invites Advisory Board pharmacy experts Gina Lohr and Chloe Bakst to unpack how providers are grappling with how to get these life-changing treatments to those that need them. Links: Ep. 210: How you approach precision medicine matters—for some patients more than others Ep. 209: Predicting what oncology will look like in 2030 4 things leaders need to know about high-cost drugs 3 takeaways on why primary care is key to migraine management Register for the Revolutions in Specialty Care Summit A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

It's no secret that healthcare is becoming more and more personalized – or “bespoke” – as increasingly sophisticated diagnostics and therapeutics continue to explode into the market. This vast pipeline is redefining the industry in several ways—but there is real risk associated if the stakeholders responsible for developing, delivering, and paying for these innovations aren’t baking health equity into their business models. Last week, in the first episode of our run up to the Advisory Board Clinical Innovation Summit: Revolutions in Specialty Care, we discussed Advisory Board’s prediction for the future of oncology. This week, host Rachel (Rae) Woods invites Advisory Board experts Amanda Okaka and Fanta Cherif to break down the health equity conundrum presented by precision medicine: Will precision medicine reduce health disparities, or exacerbate them? The answer depends on the actions—big and small—of industry leaders. Links: Register for the Revolutions in Specialty Care Summit How precision medicine can help us move from race-based to race-conscious medicine Ep. 209: Predicting what oncology will look like in 2030 Ep. 204: Unveiling "Bespoke Care": Healthcare's tailored future Bespoke care, part 1: What it is and how it’s transforming care delivery Register for the Clinical Innovation Summit A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

There has been a lot of change in the oncology space in the last few years. These changes have brought new pressures, like workforce strain, increased competition, rising spend, and more. While many leaders are worried about the "right now," it is crucial to consider how you can best position yourself for the future of cancer care. That's why, in this episode, host Rachel (Rae) Woods invites Advisory Board specialty care experts Lindsey Paul and Julia Elder to discuss why preparing for the future means making changes today. Throughout the conversation, they discuss how current pressures are changing the field of oncology and four ways cancer care will change by 2030. Links: 4 predictions for cancer care in 2030 3 strategies to leverage oncology pharmacists and improve cancer care 5 strategies to deploy (and empower) APPs in cancer care Ep. 203: Value series: Is the future of VBC in specialty care? Zing Health & Strive Health say yes. Ep. 202: Value series: Why CenterWell (and Humana) is going all in on senior care Register for the Clinical Innovation Summit A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

According to economist Jim Rebitzer and healthcare consultant Bob Rebitzer, the healthcare industry has failed in achieving what many other sectors have accomplished – improving products, while simultaneously reducing costs over time. In this episode, recorded live at The Players 2024 Championship, host Rachel (Rae) Woods invited Jim and Bob to discuss the central premise of their book, Why Not Better and Cheaper? They discussed the root causes of this challenge – including incentives, prevailing professional and social norms, and competition – that the industry must confront to deliver better and cheaper healthcare. Links: Learn more about the Rebitzer brothers and their new book, Why Not Better and Cheaper? Our Financial Impact playlist This spring Radio Advisory is celebrating four years of production. Thank you for listening! Truly personalized care is possible. Here's how to make it a reality. Learn about Advisory Board On-Demand Courses Learn about Advisory Board Fellowship A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

Radio Advisory has commemorated Nurses Week every year since we started production in April 2020. A lot has changed since the early days of the pandemic, but the reality is that we’re still grappling with a workforce crisis defined by rising burnout, turnover, and shortages. Celebrating nurses just one week out of the year will not suffice in addressing these complex issues. In this episode, host Rachel (Rae) Woods sits down with Advisory Board nursing experts Monica Westhead, Allyson Paiewonsky, and Ali Knight to discuss why the industry needs to pivot towards more sustainable strategies for their care teams, what leaders should be thinking about when training and supporting nurses, and why "top-of-license care" is an incomplete solution. Links: [Webinar] How to cultivate resilient and adaptive nurse leaders 4 ways to retain early career nurses 3 underlying causes of nurse recruitment and retention challenges A detailed look at the top 2 models for virtual nursing care 3 ways AI can help nurses AI nurses? Inside Nvidia, Hippocratic AI's new partnership Our Clinical Workforce playlist Ep. 205: Live from ViVE 2024: Four leaders on how technology is redefining clinical work Ep. 162: Addressing the workforce crisis: Insights from University Hospitals' leaders Ep. 135: Henry Ford Health on nursing shortages and the real supply chain issue 6 advantages to matching patients with compatible clinicians (sponsored by Optum Match) Learn about Advisory Board Fellowship [Webinar, May 14] Bespoke care, part 1: What it is and how it’s transforming care delivery A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

As healthcare leaders continue to contend with workforce shortages, technological shifts, and fragile financials it can be hard to predict what the future looks like for their organizations and the transformation that needs to happen to improve healthcare for all. In this episode, host Rachel (Rae) Woods invites the 24th Secretary of the U.S. Department of Health and Human Services Alex Azar to discuss what "transformation" actually means, what conditions need to be in place to mitigate financial loss, and what leaders can do to advance towards industry-wide transformation. Links: Our Value-based Care playlist Around the nation: CMS hints at more prior authorization rules Our Strategy playlist Truly personalized care is possible. Here's how to make it a reality. [Webinar, May 14] Bespoke care, part 1: What it is and how it’s transforming care delivery A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

You might be burned out from talking about burnout. But the truth is, healthcare workers are still suffering from high administrative burden, reduced autonomy, and a cycle of turnover and retirements that we cannot escape. In response, industry leaders are looking to the latest and greatest technologies to unburden their workforce and improve the mental wellbeing of their staff. But will the promise of a tech-enabled clinical workforce live up to the hype? In this special episode, recorded live from ViVE 2024, host Rachel (Rae) Woods invites Dr. Nele Jessel, Chief Medical Officer at athenahealth, Dr. Jesse Ehrenfeld, President of the American Medical Association, Dr. Syl Trepanier, SVP and System Chief Nursing Officer at Providence, and Dr. Tina Shah, Chief Clinical Officer at Abridge, to discuss the state of the workforce crisis, how new technologies are redefining work, and why emerging technologies like AI might not be a silver bullet. Links: Cloud-Based Healthcare Products & Services | athenahealth American Medical Association (ama-assn.org) World-class health care with human connection | Providence Abridge | Generative AI for Clinical Conversations How technology can help solve the workforce crisis Truly personalized care is possible. Here's how to make it a reality. [Webinar, May 14] Bespoke care, part 1: What it is and how it’s transforming care delivery A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

High-cost drugs, generative AI, diagnostic testing – the pace and sophistication of healthcare innovation has been keeping our experts busy over the past several years. At some point, they realized there was something deeper going on – a sea change in what healthcare innovation is seeking to achieve, and the world it's pushing us toward. This week, host Abby Burns invites Advisory Board innovation experts Solomon Banjo and Nick Hula to talk about a new era of innovation, where progress in diagnostics, treatments, data analysis, and ongoing management have the potential to revolutionize patient care through unprecedented customization. They define what "bespoke care" is, explain how it differs from other delivery models, and highlight the opportunities (and challenges) it presents. Want to learn more about bespoke care and what it means for the industry? Register for our upcoming webinar series in May. Links: [Webinar, May 14] Bespoke care, part 1: What it is and how it’s transforming care delivery 4 imperatives for the future of healthcare innovation Truly personalized care is possible. Here's how to make it a reality. Researchers react: Quick takes on the Clinical Innovation Summit New advances in treatment and diagnostics have the potential to deliver on one of healthcare's greatest unrealized promises: truly personalized, patient-focused care. But how can a system designed to deliver fast, standardized treatment realign itself to offer "bespoke care" to patients at scale? Visit advisory.com/bespoke to learn 4 key challenges standing in the way – and how to overcome them. Radio Advisory is celebrating its four-year anniversary this month! Tell us about your favorite episode, what you like about the podcast, and how we can continue to do better by emailing podcasts@advisory.com or leave us a voicemail through radioadvisory.advisory.com. Thanks for listening! A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

Last week, in part two of our series on value-based care, we talked about how CenterWell, Humana’s provider arm, turned to senior-focused primary care to grow their value-based strategy. But as the Medicare Advantage market gets larger, older, and sicker, it is becoming clear that a focus on primary care isn’t enough. The fact is, VBC in specialty care is the future. In part three of our value series, host Rachel (Rae) Woods invites TJ Ackerman, Senior Vice President of Provider and Network Performance at Zing Health, to discuss what good specialty care in Medicare Advantage looks like. We also talk with one of Zing’s provider partners, Will Stokes, Chief Strategy Officer at Strive Health, a leader in value-based kidney care. Together, TJ and Will discuss the importance of payer-provider partners in value-based specialty care. Links: Zing Health offers Medicare Advantage Plans in Illinois, Indiana, and Michigan. (myzinghealth.com) Transforming Kidney Care - Strive Health Register for the “Raising the Value Bar Summit” Ep. 202: Value series: Why CenterWell (and Humana) is going all in on senior care Ep. 201: Value series: What does health system VBC adoption actually look like? Use the Market Scenario Planner Learn about Advisory Board On-Demand Courses Register for the Raising the Value Bar Summit 3 strategies for facing the 'tripledemic' of respiratory viruses A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

Last week, in part one of our series on value-based care, we talked all about health systems taking on risk, and why that looks a bit different for everyone. This week, we're exploring an organization that embodies that principle. CenterWell, Humana's provider arm, is pursuing value-based care by going all in on senior focused care. So how are they doing it? In part two of our value series, host Rachel (Rae) Woods invites CenterWell President, Dr. Sanjay Shetty, to discuss the philosophy behind and strategies for pursuing value-based care through senior care management. Throughout the conversation, they discuss why this strategy is right for CenterWell, what it takes to succeed, and how they are navigating today's market challenges. Links: CenterWell | Reimagining Senior Healthcare Register for the "Raising the Value Bar Summit Ep. 201: Value series: What does health system VBC adoption actually look like? 5 insights from VBC leaders 3 strategies for facing the 'tripledemic' of respiratory viruses How CoxHealth grew their Inspire program to meet surging demand Learn about Advisory Board Fellowship A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

In a few weeks, Advisory Board will be convening leaders across the industry in New Orleans, Louisiana to talk about the meaning of "value" in healthcare. In anticipation of the Value Summit, Radio Advisory will be spending the next three weeks talking about one major expression of value in the industry – value-based care. In the first episode of our mini-series, host Abby Burns invites Advisory Board value-based care experts Clare Wirth and Daniel Kuzmanovich to paint the landscape of health system VBC adoption and break down why the road to VBC is neither linear, nor uniform. Links: Register for the "Raising the Value Bar Summit" VBC self-assessment: Find out where your organization stands 5 insights from VBC leaders Introduction to the series: Envisioning paths to nationwide VBC Ep. 178: What the industry is (still) getting wrong about value-based care Learn more about On-Demand Courses How St. Cloud ENT partnered with an ASC to improve sleep apnea outcomes and grow surgical services A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

In the last five years, the health care industry has seen an explosion of corporate ownership over medical groups. It's been relatively smooth sailing for many of these groups so far—but in 2024, they may face the same challenges as incumbents. In this episode, host Rachel (Rae) Woods invites Advisory Board physician experts Sarah Roller and Eliza Dailey to discuss why 2024 will be a make-or-break year for corporate medical groups, and what that means for the rest of the industry. Links: Bold predictions for healthcare in 2024 What you need to know about rising medical group consolidation Physician employment is changing. What does that mean for the industry? Ep. 198: PE firm General Catalyst is buying a hospital — here's our take Use Advisory Board's Clinician Supply Profiler to see how physician supply in your market compares to others. Register for Advisory Board's Clinical Innovation Summit and learn about sponsorship opportunities. Learn more about Advisory Board Fellowship. A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.

Producers' note: We know a lot of organizations have been and are being affected by the major cyberattack of Change Healthcare systems and resulting outages. We won't be addressing it in this episode, but if you have questions or are looking for more information please go to https://www.unitedhealthgroup.com/changehealthcarecyberresponse. The relationship between health plans and providers has always included an element of friction, but lately, it seems like the temperature is rising. And you've probably noticed – public contracting disputes increased by 69% between 2022 and 2023. That's why, in this episode, host Abby Burns invites Advisory Board experts Max Hakanson and Eileen Fennell to discuss why the state of affairs seems to be getting worse, how key flashpoints are fanning the flames, and what each stakeholder says they need to see from their partners in order to mend the relationship. Plus, Advisory Board digital health expert Ty Aderhold makes a cameo appearance to help answer the question: Is AI the solution here? Links: 7 things we want to fix in 2024 (and how to get there) A new era of payer-provider relationships The new era of provider enablement AI in healthcare: Insights from 10 C-suite executives 2024 Raising the Value Bar Summit A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.